✦ LIBER ✦

A study on the relationship between breast cancer molecular classification and prognosis

✍ Scribed by X.S. Chen; K.W. Shen; W.T. Yang; H.F. Lu; J. Wu; J.S. Lu; Z.M. Shao; Z.Z. Shen

Book ID: 119598263
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 58 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70771-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The relationship between prognosis and l

The relationship between prognosis and lymphocyte response to PHA in breast cancer

✍ Bolton, P M; Whitehead, R H; Newcombe, R G; James, S L; Hughes, L E 📂 Article 📅 1975 🏛 Nature Publishing Group 🌐 English ⚖ 336 KB

A study on telomerase activity and progn

A study on telomerase activity and prognosis in breast cancer

✍ M. Kimura; T. Koida; Y. Yanagita 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 80 KB

A multivariate study of the relationship

A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer

✍ Masakuni Noguchi; Takao Taniya; Naohiro Koyasaki; Nagayoshi Ohta; Itsuo Miyazaki 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 598 KB

The relationship between nm23 gene expre

The relationship between nm23 gene expression and distal metastasis and prognosis in breast cancer

✍ Mao Huisheng; Liu Hong; Li Shilling; Fu Xilin; Feng Yumei 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Defining breast cancer prognosis based o

Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study

✍ Shaheenah Dawood; Rong Hu; Michelle D. Homes; Laura C. Collins; Stuart J. Schnit 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 218 KB

Relationship between p53 gene abnormalit

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

✍ Ram Seshadri; Anthony S.-Y. Leong; Kieran McCaul; Frank A. Firgaira; Vittal Setl 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 757 KB

The prognostic significance of p53 gene abnormalities was investigated in 9 I9 primary breast-cancer patients. p53 expression and tumour-cell proliferation fraction determined by MIB-I count, p53 exon 5 and 6 mutations and HER-Z/neu oncogene amplification were detected by immunohistochemistry, PCR-S